Efficacy of Intravenous Levosimendan Compared With Dobutamine on Renal Hemodynamics and Function in Chronic Heart Failure
Phase of Trial: Phase III
Latest Information Update: 11 Feb 2019
Price : $35 *
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms ELDOR
- 31 Aug 2018 Biomarkers information updated
- 28 Aug 2018 According to a Tenax Therapeutics media release, data from this study were published in the Journal of the American Heart Association on Aug 2018.
- 28 Aug 2018 Results presented in a Tenax Therapeutics media release.